Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Windgap Medical, Inc. Closes Over $39 Million Of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal
PRIVATEJan 20, 2022•over 4 years ago
Amount Raised
$39 Million
Round Type
Series B
WatertownHealthcareHealth CareGovernment And Military
Description
Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced today that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital. This equity round of investment expanded beyond an initial target of approximately $32 million due to strong investor interest. This equity financing is also supported by existing investors, including Shepherd Kaplan Krochuk (SKK) and Molex Ventures (a Koch Industries company), along with new investors including Cobro Ventures, and others.
Company Information
Company
Windgap Medical
Location
200 Dexter Avenue
Watertown, Massachusetts, United States
About
Windgap Medical offers autoinjector platforms for complex injectables, freeing patients, families and potential treatments from the limitations of current technology. Its first product is for the administration of adrenaline for anaphylaxis, with additional products under development.
Don't miss Windgap Medical's next move
Get an email the moment Windgap Medical raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts32 people are listed at Windgap Medical. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for Windgap Medical's next move
WatertownHealthcareHealth CareGovernment And Military